Drug shortage
Gefitinib Tablet · Apotex Corp.
FDA drug shortage · To Be Discontinued · updated Feb 5, 2025
Key facts
| Generic name | Gefitinib Tablet |
|---|---|
| Proprietary name | Gefitinib |
| Company | Apotex Corp. |
| Presentation | Gefitinib, Tablet, 250 mg (NDC 60505-4512-3) |
| Dosage form | Tablet |
| Strength | 250 mg |
| Status | To Be Discontinued |
| Therapeutic category | Oncology |
| Package NDCs | 60505-4512-3 |
| First posted | Feb 5, 2025 |
| Last updated | Feb 5, 2025 |
| Discontinued | Feb 5, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: